Thiophene carboxamides with ndm-1 inhibitory activity
A technology of thiophene carboxamides and compounds, applied in the field of thiophene carboxamides and their preparation, can solve problems such as high sensitivity in vitro, and achieve the effects of improving curative effect, alleviating drug resistance, and treating drug-resistant bacterial infections
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Publication Date
- 2016-07-13
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medicinal chemistry, in particular to thiophenecarboxamide compounds and their preparation methods and applications. Background technique
[0002] Antibiotics are a class of chemical substances produced by certain microorganisms in the course of life, which can inhibit or kill some other pathogenic microorganisms. It is also the main weapon for humans to resist bacterial infections. However, in August 2010, the famous medical journal "The Lancet" reported a case of resistance to all β-lactam antibiotics, insensitive to ciprofloxacin, and only sensitive to colistin. It carries a new type of metallo-beta-lactamase encoded by Klebsiella pneumoniae (Klebsiellapneumoniae), and this enzyme is named New Delhi metallo-beta-lactamase (NDM-1, New Delhimetallo-β-lactamase-1). This enzyme can exist in the DNA of Escherichia coli to make it widely resistant to drugs, and it is difficult for people to be cured or even die afte...
Examples
preparation example Construction
[0037] The starting materials used in the preparation of the compounds of the present invention are known, can be prepared according to known methods, or are commercially available.
[0038] Both intermediates and final products can be worked up and / or purified according to conventional methods, including pH adjustment, extraction, filtration, drying, concentration, chromatography, trituration, crystallization, and the like.
[0039] In addition, the compounds of the present invention can be prepared by various methods known in the art or variations on the methods described herein.
[0040] The following examples are only used to illustrate the present invention, and do not limit the present invention in any way.
Embodiment 1
[0041] The preparation of embodiment 1N-(4-bromo-3-fluorophenyl)-2-thiophenecarboxamide
[0042]
[0043] Put 2-thiophenecarboxylic acid (8mmol, 1.025g) into a 100ml flask, add thionyl chloride (28mmol, 3.331g), reflux for 30min, and evaporate the mixture under reduced pressure with a rotary evaporator (Shanghai Yarong) to remove thionyl chloride sulfone. Then the residue was placed in an ice bath, and 3-fluoro-4-bromoaniline (16 mmol, 3.04 g) and triethylamine (10 mmol, 1.012 g) dissolved in 15 ml of dichloromethane were slowly added to the residue, Reflux for 1h. with saturated NaHCO 3 Wash the reaction solution, separate the water phase until the pH of the water phase is approximately equal to 8, then wash the organic phase with 10ml of water, and wash it over anhydrous Na 2 SO 4 After drying and filtering, the filtrate was concentrated to dryness, and the residue was recrystallized from ethanol to obtain 2.08 g of the title compound with a yield of 87%. The compoun...
Embodiment 2
[0044] The preparation of embodiment 2N-(3-fluorobenzyl)-2-thiophene carboxamide
[0045]
[0046] Using 3-fluorobenzylamine instead of 3-fluoro-4-bromoaniline in Example 1, the same method as Example 1 was used to prepare this compound with a yield of 87%. The compound is a white powder, and its identification data are as follows: M.P.: 100.0-101.0°C; ESI-MSm / z: 236.22 ([M+H + ]); 1 HNMR (600MHz, CDCl 3 , δppm): 7.60 (s, 1H), 7.46 (s, 1H), 7.27-7.18 (m, 2H), 7.02 (m, 3H), 6.91 (m, 1H), 4.52 (s, 2H); 13 CNMR (150MHz, CDCl 3 ): 163.8, 162.1, 140.9, 138.7, 136.1, 135.6, 131.9, 130.2, 128.8, 127.7, 127.8, 114.4, 43.3.